- Di processo
- Research on the gut microbiota is reshaping gastroenterology, but clinical application remains difficult due to heterogeneous data and evolving diagnostics. Microbiota – road to 2026 provides clinicians with a rigorous update on dysbiosis, medication effects, and the role of microbiota in upper gi diseases, ibs and other gut–brain disorders, diverticular disease, and debated topics like sibo and imo. Through lectures and case-based discussions, the program strengthens critical interpretation of emerging evidence and supports evidence-based, clinically sound management.